Methotrexate Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
Conditions:   Arthritis;   Arthralgia Intervention:   Drug: Methotrexate Sponsor:   AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Condition:   Non-hodgkin Lymphoma Interventions:   Drug: Methotrexate;   Drug: Rituximab (where available);   Drug: Ibrutinib Sponsors:   Canadian Cancer Trials Group;   Janssen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
Conditions:   Arthritis;   Arthralgia Intervention:   Drug: Methotrexate Sponsor:   AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Condition:   Non-hodgkin Lymphoma Interventions:   Drug: Methotrexate;   Drug: Rituximab (where available);   Drug: Ibrutinib Sponsors:   Canadian Cancer Trials Group;   Janssen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
Conditions:   Arthritis;   Arthralgia Intervention:   Drug: Methotrexate Sponsor:   AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Condition:   Non-hodgkin Lymphoma Interventions:   Drug: Methotrexate;   Drug: Rituximab (where available);   Drug: Ibrutinib Sponsors:   Canadian Cancer Trials Group;   Janssen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
Conditions:   Arthritis;   Arthralgia Intervention:   Drug: Methotrexate Sponsor:   AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Condition:   Non-hodgkin Lymphoma Interventions:   Drug: Methotrexate;   Drug: Rituximab (where available);   Drug: Ibrutinib Sponsors:   Canadian Cancer Trials Group;   Janssen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials